These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 33009241)

  • 41. 24-Hour ambulatory blood pressure control with triple-therapy amlodipine, valsartan and hydrochlorothiazide in patients with moderate to severe hypertension.
    Lacourcière Y; Crikelair N; Glazer RD; Yen J; Calhoun DA
    J Hum Hypertens; 2011 Oct; 25(10):615-22. PubMed ID: 21248785
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and tolerability of the combination valsartan/hydrochlorothiazide compared with amlodipine in a mild-to-moderately hypertensive Brazilian population.
    Franco RJ; Goldflus S; McQuitty M; Oigman W;
    Blood Press Suppl; 2003 Dec; 2():41-7. PubMed ID: 14761076
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of hypertension with the fixed combination of perindopril and amlodipine in daily clinical practice: results from the STRONG prospective, observational, multicenter study.
    Bahl VK; Jadhav UM; Thacker HP
    Am J Cardiovasc Drugs; 2009; 9(3):135-42. PubMed ID: 19463019
    [TBL] [Abstract][Full Text] [Related]  

  • 44. I-COMBINE study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with amlodipine monotherapy in hypertensive patients uncontrolled with amlodipine 5 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study.
    Bobrie G;
    Clin Ther; 2012 Aug; 34(8):1705-19. PubMed ID: 22853848
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An ambulatory blood pressure monitoring study of the comparative antihypertensive efficacy of two angiotensin II receptor antagonists, irbesartan and valsartan.
    Mancia G; Korlipara K; van Rossum P; Villa G; Silvert B
    Blood Press Monit; 2002 Apr; 7(2):135-42. PubMed ID: 12048432
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of single-pill strategies first line in hypertension: perindopril/amlodipine versus valsartan/amlodipine.
    Mancia G; Asmar R; Amodeo C; Mourad JJ; Taddei S; Gamba MA; Chazova IE; Puig JG
    J Hypertens; 2015 Feb; 33(2):401-11. PubMed ID: 25380149
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomized, comparative, multicentric evaluation of atenolol/amlodipine combination with atenolol alone in essential hypertensive patients.
    Pareek A; Salkar H; Mulay P; Desai S; Chandurkar N; Redkar N
    Am J Ther; 2010; 17(1):46-52. PubMed ID: 19535971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Amlodipine/valsartan 5/160 mg versus valsartan 160 mg in Chinese hypertensives.
    Zhu D; Yang K; Sun N; Gao P; Wang R; Grosso A; Zhang Y;
    Int J Cardiol; 2013 Sep; 167(5):2024-30. PubMed ID: 22647413
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combination.
    Volpe M; Christian Rump L; Ammentorp B; Laeis P
    Clin Drug Investig; 2012 Oct; 32(10):649-64. PubMed ID: 22909147
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of baseline blood pressure in guiding treatment choice: a secondary analysis of the use of valsartan/hydrochlorothiazide as initial therapy in hypertensive adults in a randomized, double-blind, placebo-controlled trial.
    Pool JL; Glazer R; Crikelair N; Levy D
    Clin Drug Investig; 2009; 29(12):791-802. PubMed ID: 19888785
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial.
    Sohn IS; Kim CJ; Oh BH; Hong TJ; Park CG; Kim BS; Chung WB;
    Am J Cardiovasc Drugs; 2016 Apr; 16(2):129-38. PubMed ID: 26691333
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of valsartan and amlodipine on ambulatory and morning blood pressure in hypertensive patients.
    Eguchi K; Kario K; Hoshide Y; Hoshide S; Ishikawa J; Morinari M; Ishikawa S; Shimada K
    Am J Hypertens; 2004 Feb; 17(2):112-7. PubMed ID: 14751651
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of valsartan/hydrochlorothiazide fixed-dose combination compared with amlodipine monotherapy as first-line therapy for mild to moderate hypertension.
    Chao CL; Lin YH; Lin LC; Lin LY; Tsai CT; Wang YC; Hwang JJ; Chen JC; Chiang FT
    J Int Med Res; 2009; 37(2):289-97. PubMed ID: 19383221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effectiveness of add-on therapy with amlodipine in hypertensive patients receiving valsartan.
    Weycker D; Keskinaslan A; Levy DG; Edelsberg J; Kartashov A; Oster G
    Blood Press Suppl; 2008 Dec; 2():5-12. PubMed ID: 19205091
    [TBL] [Abstract][Full Text] [Related]  

  • 56. S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial.
    Jo SH; Park SJ; Kim EJ; Kim SJ; Cho HJ; Song JM; Shin J; Park JJ; Shin JH; Han KR; Choi DJ
    Trials; 2018 Jun; 19(1):324. PubMed ID: 29925421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and tolerability between an olmesartan/amlodipine fixed-dose combination and an amlodipine double dose in mild to moderate hypertension.
    Lin TH; Tsai CD; Pan JP; Hou CJ; Hsia CH; Tsai JP; Lai WT
    Kaohsiung J Med Sci; 2013 May; 29(5):265-70. PubMed ID: 23639513
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical Effectiveness, Safety and Tolerability of Amlodipine/Valsartan in Hypertensive Patients: the Indonesian Subset of the EXCITE Study.
    Setiawati A; Kalim H; Abdillah A
    Acta Med Indones; 2015 Jul; 47(3):223-33. PubMed ID: 26586388
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Valsartan 160 mg/Amlodipine 5 mg Combination Therapy versus Amlodipine 10 mg in Hypertensive Patients with Inadequate Response to Amlodipine 5 mg Monotherapy.
    Sung J; Jeong JO; Kwon SU; Won KH; Kim BJ; Cho BR; Kim MK; Lee S; Kim HJ; Lim SH; Park SW; Park JE
    Korean Circ J; 2016 Mar; 46(2):222-8. PubMed ID: 27014353
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An eight-week, multicenter, randomized, double-blind study to evaluate the efficacy and tolerability of fixed-dose amlodipine/benazepril combination in comparison with amlodipine as first-line therapy in chinese patients with mild to moderate hypertension.
    Ueng KC; Lin LC; Voon WC; Lin MC; Liu YB; Su HM; Chang PY; Lin TH; Chen WL; Wu CC; Lai WT; Lin CS
    Blood Press Suppl; 2008 Jun; 1():24-31. PubMed ID: 18705532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.